PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · IEX Real-Time Price · USD
51.79
-0.20 (-0.38%)
At close: Apr 17, 2024, 4:00 PM
52.34
+0.55 (1.06%)
After-hours: Apr 17, 2024, 7:59 PM EDT
Company Description
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally.
The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).
It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH.
PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
PROCEPT BioRobotics Corporation
| Country | United States |
| Founded | 2009 |
| IPO Date | Sep 15, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 626 |
| CEO | Dr. Reza Zadno Ph.D. |
Contact Details
Address: 150 Baytech Drive San Jose, California 95134 United States | |
| Phone | (650) 232-9832 |
| Website | procept-biorobotics.com |
Stock Details
| Ticker Symbol | PRCT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $25.00 |
| CIK Code | 0001588978 |
| CUSIP Number | 74276L105 |
| ISIN Number | US74276L1052 |
| Employer ID | 26-0199180 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Reza Zadno Ph.D. | President, Chief Executive Officer and Director |
| Kevin Waters | Executive Vice President and Chief Financial Officer |
| Alaleh Nouri | EVice President, Chief Legal Officer and Corporate Secretary |
| Hisham Shiblaq | Executive Vice President and Chief Commercial Officer |
| Mohan F. Sancheti | Senior Vice President of Operations |
| Barry Templin | Executive Vice President of Technology and Clinical Development |
| Matthew James Bacso C.F.A. | Vice President of Investor Relations |
| Stacey L. Porter | Chief People Officer |
| Bijesh Chandran | Senior Vice President of Regulatory Affairs and Quality Assurance |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 4, 2024 | 144 | Filing |
| Feb 28, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 28, 2024 | 10-K | Annual Report |
| Feb 27, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 7, 2024 | 144 | Filing |
| Feb 7, 2024 | 144 | Filing |
| Jan 26, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |